Skip to Content

746 Results Found

  • Article
  • Open Access
10 Citations
3,495 Views
24 Pages

Development and Characterization of Pharmaceutical Systems Containing Rifampicin

  • Antonella V. Dan Córdoba,
  • Virginia Aiassa,
  • Jesica A. Dimmer,
  • Camila N. Barrionuevo,
  • Mario A. Quevedo,
  • Marcela R. Longhi and
  • Ariana Zoppi

Rifampicin is a potent antimicrobial drug with some suboptimal properties, such as poor stability, low solubility, and variable bioavailability. Therefore, in the current study, a multicomponent complex between rifampicin, γ-cyclodextrin, and a...

(This article belongs to the Special Issue Drug Stability and Stabilization Techniques Volume II)
  • Article
  • Open Access
10 Citations
4,178 Views
21 Pages

Stimuli-Responsive Rifampicin-Based Macromolecules

  • Izabela Zaborniak,
  • Angelika Macior and
  • Paweł Chmielarz

31 August 2020

This paper presents the modification of the antibiotic rifampicin by an anionic polyelectrolyte using a simplified electrochemically mediated atom transfer radical polymerization (seATRP) technique to receive stimuli-responsive polymer materials. Ini...

(This article belongs to the Special Issue Atom Transfer Radical Polymerization (ATRP) in Synthesis of Precisely Defined Polymers)
  • Article
  • Open Access
5 Citations
3,638 Views
14 Pages

Several reports have suggested a role for Corynebacterium striatum as an opportunistic pathogen. The authors have conducted a retrospective study at the Clinical Center of the University of Szeged, Hungary, between 2012 and 2021 that revealed signifi...

(This article belongs to the Special Issue Women’s Special Issue Series: Pathogens)
  • Article
  • Open Access
56 Citations
10,106 Views
17 Pages

Composition Influence on Pulmonary Delivery of Rifampicin Liposomes

  • Maria Letizia Manca,
  • Chiara Sinico,
  • Anna Maria Maccioni,
  • Octavio Diez,
  • Anna Maria Fadda and
  • Maria Manconi

27 November 2012

The effects of lipid concentration and composition on the physicochemical properties, aerosol performance and in vitro toxicity activity of several rifampicin-loaded liposomes were investigated. To this purpose, six liposome formulations containing d...

(This article belongs to the Special Issue Drug Delivery Using Nanotechnology)
  • Article
  • Open Access
35 Citations
5,364 Views
19 Pages

Nanoparticle-Based Rifampicin Delivery System Development

  • Marjan Motiei,
  • Luis Pleno de Gouveia,
  • Tomáš Šopík,
  • Robert Vícha,
  • David Škoda,
  • Jaroslav Císař,
  • Reza Khalili,
  • Eva Domincová Bergerová,
  • Lukáš Münster and
  • Petr Sáha
  • + 2 authors

The alkaline milieu of chronic wounds severely impairs the therapeutic effect of antibiotics, such as rifampicin; as such, the development of new drugs, or the smart delivery of existing drugs, is required. Herein, two innovative polyelectrolyte nano...

  • Article
  • Open Access
9 Citations
8,962 Views
16 Pages

Cutibacterium acnes Prosthetic Joint Infections: Is Rifampicin-Combination Therapy Beneficial?

  • Grégoire Saltiel,
  • Vanina Meyssonnier,
  • Younes Kerroumi,
  • Beate Heym,
  • Olivier Lidove,
  • Simon Marmor and
  • Valérie Zeller

11 December 2022

No consensus has been reached on the optimal antibiotic regimen to treat Cutibacterium acnes PJIs (Ca-PJIs). In vitro studies showed excellent rifampicin efficacy against biofilm-associated C. acnes infections, but clinical studies did not confirm th...

(This article belongs to the Special Issue Prosthetic Joint Infection: The Challenges of Prevention, Diagnosis and Treatment and Opportunities for Future Research - 2nd Volume)
  • Article
  • Open Access
63 Citations
9,522 Views
15 Pages

Rifampicin-Loaded Mesoporous Silica Nanoparticles for the Treatment of Intracellular Infections

  • Santhni Subramaniam,
  • Nicky Thomas,
  • Hanna Gustafsson,
  • Manasi Jambhrunkar,
  • Stephen P. Kidd and
  • Clive A. Prestidge

Infectious diseases remain a major burden in today’s world, causing high mortality rates and significant economic losses, with >9 million deaths per year predicted by 2030. Invasion of host cells by intracellular bacteria poses treatment cha...

(This article belongs to the Special Issue From the Southern Hemisphere: Research on Resistance, Antibiotics and Treatments)
  • Article
  • Open Access
1 Citations
1,710 Views
18 Pages

Guanethidine Enhances the Antibacterial Activity of Rifampicin Against Multidrug-Resistant Bacteria

  • Xiaoou Zhao,
  • Zhendu Zhang,
  • Lizai Liu,
  • Duojia Wang,
  • Xin Zhang,
  • Luobing Zhao,
  • Yunhui Zhao,
  • Xiangshu Jin,
  • Lei Wang and
  • Xiaoxiao Liu

The escalating global threat of antibiotic resistance necessitates innovative strategies, such as the combination of antibiotics with adjuvants. Monotherapy with rifampicin is more likely to induce resistance in pathogens compared to other antibiotic...

(This article belongs to the Topic Antimicrobial Agents and Nanomaterials)
  • Article
  • Open Access
1 Citations
1,289 Views
11 Pages

17 October 2025

Background/Objectives: In staphylococcal implant infections, there is often discussion about the optimal postoperative timing of the introduction of rifampicin in the postoperative period with open wounds. Methods: We reviewed all adult patients with...

  • Review
  • Open Access
556 Views
24 Pages

7 September 2026

Background. Osteoarticular infections (OAI)—including prosthetic joint infections (PJI), fracture-related infections (FRI), and osteomyelitis—are challenging to cure because bacterial biofilm on implant surfaces confers up to 1000-fold an...

(This article belongs to the Section Antibiotic Therapy in Infectious Diseases)
  • Article
  • Open Access
80 Citations
12,957 Views
13 Pages

Mechanism Investigation of Rifampicin-Induced Liver Injury Using Comparative Toxicoproteomics in Mice

  • Ju-Hyun Kim,
  • Woong Shik Nam,
  • Sun Joo Kim,
  • Oh Kwang Kwon,
  • Eun Ji Seung,
  • Jung Jae Jo,
  • Riya Shresha,
  • Tae Hee Lee,
  • Tae Won Jeon and
  • Sangkyu Lee
  • + 2 authors

Tuberculosis is one of the top causes of death among curable infectious diseases; it is an airborne infectious disease that killed 1.1 million people worldwide in 2010. Anti-tuberculosis drug-induced liver injury is the primary cause of drug-induced...

(This article belongs to the Special Issue Molecular Research on Drug Induced Liver Injury)
  • Article
  • Open Access
4 Citations
3,109 Views
18 Pages

15 February 2025

Drug repurposing is a cost-effective and innovative strategy for identifying new therapeutic applications for existing drugs, thereby shortening development timelines and accelerating the availability of treatments. Applying this approach to the deve...

(This article belongs to the Special Issue Advances in Chemistry of Cosmetics)
  • Article
  • Open Access
12 Citations
3,135 Views
11 Pages

Incidence of Rifampicin Resistance in Periprosthetic Joint Infection: A Single-Centre Cohort Study on 238 Patients

  • Stergios Lazarinis,
  • Nils P. Hailer,
  • Josef D. Järhult and
  • Anders Brüggemann

30 September 2023

Background. Rifampicin is a pillar in the treatment of periprosthetic joint infection (PJI). However, rifampicin resistance is an increasing threat to PJI treatment. This study explores the incidence of rifampicin-resistant bacteria over time in a Sw...

(This article belongs to the Special Issue Antibiotic Therapy in Implant Related Orthopedic Infections)
  • Article
  • Open Access
33 Citations
8,478 Views
28 Pages

The degradation of rifampicin (RIF) in an acidic medium to form 3-formyl rifamycin SV, a poorly absorbed compound, is accelerated in the presence of isoniazid, contributing to the poor bioavailability of rifampicin. This manuscript presents a novel a...

(This article belongs to the Special Issue Encapsulation Techniques Applied to Pharmaceutics)
  • Article
  • Open Access
12 Citations
3,297 Views
9 Pages

The RNA Polymerase Inhibitor Corallopyronin A Has a Lower Frequency of Resistance Than Rifampicin in Staphylococcus aureus

  • Jan Balansky,
  • Kenneth Pfarr,
  • Christiane Szekat,
  • Stefan Kehraus,
  • Tilman Aden,
  • Miriam Grosse,
  • Rolf Jansen,
  • Thomas Hesterkamp,
  • Andrea Schiefer and
  • Gabriele Bierbaum
  • + 3 authors

Corallopyronin A (CorA) is active against Gram-positive bacteria and targets the switch region of RNA polymerase. Because of the high frequency of mutation (FoM) leading to rifampicin resistance, we determined the CorA FoM in S. aureus using fluctuat...

(This article belongs to the Section Novel Antimicrobial Agents)
  • Article
  • Open Access
1 Citations
2,420 Views
13 Pages

6 December 2024

Hydroxypropyl-β-cyclodextrin (HPβCD) is a derivatized cyclodextrin in which several H atoms on the hydroxyls of the glucose rings are substituted by 2-hydroxypropyl groups. The cyclic structure of HPβCD creates a cavity capable of tota...

  • Article
  • Open Access
3,328 Views
22 Pages

Development of Rifampicin Eye Drops for the Treatment of Exudative Age-Related Macular Degeneration

  • Valory Anne S. Vailoces,
  • Andrew J. Tolentino,
  • Jose Fernando Arevalo,
  • Ron A. Adelman,
  • Robert Bhisitkul,
  • Diana V. Do,
  • Quan Dong Nguyen,
  • Michael J. Tolentino,
  • Masaki Tanito and
  • Hiroaki Serizawa

29 April 2025

Background/Objectives: Exudative age-related macular degeneration (AMD) is a disease of choroidal neovascularization that causes blindness. Current treatments to preserve vision in this prevalent and blinding condition are repeat intraocular injectio...

(This article belongs to the Section Pharmaceutical Technology)
  • Article
  • Open Access
9 Citations
3,311 Views
9 Pages

28 August 2021

In this work, a new sensitive voltammetric method for the determination of rifampicin without time-consuming preconcentration is presented. The objective was to develop a simple, fast and sensitive voltammetric procedure for the analysis of rifampici...

(This article belongs to the Section Nanosensors)
  • Article
  • Open Access
13 Citations
4,503 Views
20 Pages

Pharmaceutical Development of Nanostructured Vesicular Hydrogel Formulations of Rifampicin for Wound Healing

  • Chantal M. Wallenwein,
  • Verena Weigel,
  • Götz Hofhaus,
  • Namrata Dhakal,
  • Wolfgang Schatton,
  • Svetlana Gelperina,
  • Florian K. Groeber-Becker,
  • Jennifer Dressman and
  • Matthias G. Wacker

19 December 2022

Chronic wounds exhibit elevated levels of inflammatory cytokines, resulting in the release of proteolytic enzymes which delay wound-healing processes. In recent years, rifampicin has gained significant attention in the treatment of chronic wounds due...

(This article belongs to the Special Issue Nanostructured Formulations in Pharmaceutical, Medical and Cosmetic Applications 2.0)
  • Article
  • Open Access
3 Citations
2,879 Views
14 Pages

Development of a Method for the Determination of Rifaximin and Rifampicin Residues in Foods of Animal Origin

  • Li-Ping Fan,
  • Qi Tao,
  • Xiao-Qiao Wang,
  • Xiao-Hui Xu,
  • Ya-Jun Yang and
  • Jian-Yong Li

27 September 2024

Rifaximin and rifampicin are good broad-spectrum antimicrobials. The irrational use of antimicrobial drugs in veterinary clinics could threaten public health and food safety. It is necessary to develop a reliable detection method of the residue for e...

(This article belongs to the Section Analytical Chemistry)
  • Article
  • Open Access
4 Citations
4,536 Views
16 Pages

Rifampicin Enhanced Carbapenem Activity with Improved Antibacterial Effects and Eradicates Established Acinetobacter baumannii Biofilms

  • Lois Chinwe Nwabor,
  • Arnon Chukamnerd,
  • Ozioma Forstinus Nwabor,
  • Rattanaruji Pomwised,
  • Supayang P. Voravuthikunchai and
  • Sarunyou Chusri

23 March 2023

Biofilm-mediated infections are critical to public health and a leading cause of resistance among pathogens, amounting to a prolonged hospital stay and increased mortality rate in the intensive care unit. In this study, the antibacterial and antibiof...

(This article belongs to the Section Medicinal Chemistry)
  • Article
  • Open Access
359 Views
26 Pages

Removal of Antibiotics Vancomycin and Rifampicin from Water by Granular Activated Carbon

  • Hamed Rasouli Sadabad,
  • Heather M. Coleman,
  • James S. G. Dooley,
  • William J. Snelling,
  • Barry O’Hagan,
  • Alexey Y. Ganin and
  • Joerg Arnscheidt

31 August 2026

In this study, the removal of vancomycin and rifampicin from aqueous media by three types of granular activated carbon was investigated under a wide range of operational conditions. There is growing concern about antimicrobial resistance to vancomyci...

(This article belongs to the Section Water Quality and Contamination)
  • Article
  • Open Access
10 Citations
4,023 Views
20 Pages

Montmorillonite–Rifampicin Nanohybrid for pH-Responsive Release of the Tuberculostatic

  • Elmar Damasceno Junior,
  • Raquel de Melo Barbosa,
  • Rita de Cássia Dantas da Silva,
  • Felipe dos Santos Costa,
  • Djalma Ribeiro da Silva,
  • César Viseras,
  • Luana Perioli and
  • Nedja Suely Fernandes

The present work describes the development of a hybrid and pH-responsive system for rifampicin using the clay mineral ‘montmorillonite’ as a nanocarrier. The influence of operational variables on the drug incorporation process was evaluat...

(This article belongs to the Special Issue Advanced Bio-Hybrid Materials for Drug Delivery Systems - New Trends and Perspectives)
  • Article
  • Open Access
22 Citations
4,891 Views
21 Pages

Polymeric Microparticles: Synthesis, Characterization and In Vitro Evaluation for Pulmonary Delivery of Rifampicin

  • Faiqa Falak Naz,
  • Kifayat Ullah Shah,
  • Zahid Rasul Niazi,
  • Mansoor Zaman,
  • Vuanghao Lim and
  • Mulham Alfatama

19 June 2022

Rifampicin, a potent broad-spectrum antibiotic, remains the backbone of anti-tubercular therapy. However, it can cause severe hepatotoxicity when given orally. To overcome the limitations of the current oral therapy, this study designed inhalable spr...

(This article belongs to the Special Issue Intelligent Polymeric Delivery System for Biomedical Applications)
  • Article
  • Open Access
24 Citations
3,663 Views
15 Pages

Magnetic Zinc Oxide/Manganese Ferrite Composite for Photodegradation of the Antibiotic Rifampicin

  • Filipe da Silva Duarte,
  • Amanda Lys Matos dos Santos Melo,
  • Alice de Barros Ferro,
  • Carmem Lúcia de Paiva e Silva Zanta,
  • José Leandro da Silva Duarte and
  • Rosane Maria Pessoa Betânio Oliveira

18 November 2022

In this study, a composite of zinc oxide and manganese ferrite was synthesized using co-precipitation and hydrothermal routes, to be used as photocatalysts in reactions with UV/Vis light source. The synthesized materials were characterized by FTIR, X...

(This article belongs to the Section Energy Materials)
  • Article
  • Open Access
1 Citations
781 Views
21 Pages

Mucoadhesive Chitosan–Gellan Gum Nanoparticles for Rifampicin Delivery: Taguchi Optimization and In Vitro Release Behavior

  • Siu-Yin Cheung,
  • Aldana Galiyeva,
  • Yerkeblan Tazhbayev,
  • Tolkyn Zhumagaliyeva,
  • Yuliia Bardadym and
  • Vladimir Aseyev

Background/Objectives: Tuberculosis treatment remains challenging due to the limited stability and side effects of conventional rifampicin formulations. This study aimed to synthesize and optimize mucoadhesive chitosan–gellan gum nanoparticles...

(This article belongs to the Section Drug Delivery and Controlled Release)
  • Article
  • Open Access
27 Citations
5,288 Views
13 Pages

Rifampicin–Liposomes for Mycobacterium abscessus Infection Treatment: Intracellular Uptake and Antibacterial Activity Evaluation

  • Federica Rinaldi,
  • Patrizia Nadia Hanieh,
  • Simona Sennato,
  • Federica De Santis,
  • Jacopo Forte,
  • Maurizio Fraziano,
  • Stefano Casciardi,
  • Carlotta Marianecci,
  • Federico Bordi and
  • Maria Carafa

Treatment of pulmonary infections caused by Mycobacterium abscessus are extremely difficult to treat, as this species is naturally resistant to many common antibiotics. Liposomes are vesicular nanocarriers suitable for hydrophilic and lipophilic drug...

(This article belongs to the Special Issue Pharmaceutics and Drug Delivery in Italy)
  • Article
  • Open Access
3 Citations
5,554 Views
18 Pages

C9orf72 Hexanucleotide Repeat Expansion-Related Neuropathology Is Attenuated by Nasal Rifampicin in Mice

  • Yukari Hatanaka,
  • Tomohiro Umeda,
  • Keiko Shigemori,
  • Toshihide Takeuchi,
  • Yoshitaka Nagai and
  • Takami Tomiyama

The non-coding GGGGCC hexanucleotide repeat expansion (HRE) in C9orf72 gene is a dominant cause of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). This intronic mutation elicits the formation of nuclear and cytoplasmic inclusio...

(This article belongs to the Special Issue Molecular Mechanisms and Treatments on Neurodegenerative Diseases)
  • Article
  • Open Access
5 Citations
2,768 Views
18 Pages

Rifampicin-Loaded PLGA/Alginate-Grafted pNVCL-Based Nanoparticles for Wound Healing

  • Tudor Bibire,
  • Daniel Vasile Timofte,
  • Radu Dănilă,
  • Alina-Diana Panainte,
  • Cătălina Natalia Yilmaz,
  • Nela Bibire,
  • Luminița Agoroaei and
  • Cristina Mihaela Ghiciuc

26 October 2024

The topical therapy with rifampicin (RF)-based formulations is beneficial for treating postoperative wound infections and to accelerate healing. Despite recent research highlighting the antibiotic’s significant anti-inflammatory properties, lim...

  • Article
  • Open Access
1 Citations
2,154 Views
11 Pages

Background/Objectives: Periprosthetic joint infection (PJI) is a severe complication that follows arthroplasty and occurs in approximately 2% of all cases. One of several cornerstones of therapy is an optimized antibiotic regimen. Early administratio...

(This article belongs to the Special Issue Advances in the Field of Biofilm-Associated Musculoskeletal Infections)
  • Article
  • Open Access
4 Citations
2,875 Views
15 Pages

Pseudomonas aeruginosa poses a significant global concern in human and veterinary medicine due to its resistance to multiple antimicrobials. Limited research has been carried out on rifampicin-resistant P. aeruginosa, particularly in food-producing a...

  • Article
  • Open Access
13 Citations
3,819 Views
9 Pages

Multiwalled Carbon Nanotubes-CeO2 Nanorods: A “Nanonetwork” Modified Electrode for Detecting Trace Rifampicin

  • Na Zhang,
  • Mariela Brites Helu,
  • Keying Zhang,
  • Xia Fang,
  • Hu Yin,
  • Jinmin Chen,
  • Shangshang Ma,
  • Aidong Fang and
  • Cong Wang

23 February 2020

Herein, a “nanonetwork” modified electrode was fabricated based on multiwalled carbon nanotubes and CeO2 nanorods. Scanning electron microscopy, X-ray powder diffraction and zeta potential were employed to characterize this electrode. Mul...

  • Case Report
  • Open Access
1 Citations
1,583 Views
8 Pages

Rectal Administration of Rifampicin and Isoniazid Suppositories: An Alternative Approach for the Treatment of Tuberculosis in a Patient with Multiple Comorbidities

  • Ioana Munteanu,
  • Beatrice Burdușel,
  • Catalin Constantin Coca,
  • Dănuț Zisu,
  • Constantin Gheorghevici,
  • George Alexandru Diaconu,
  • Diana Georgiana Stan,
  • Nicolae Feraru,
  • Andrei Tivda and
  • Corina Marginean
  • + 2 authors

12 May 2025

This article reports the case of a patient with a gastric neoplasm and total gastrectomy, presenting with severe digestive intolerance, who developed peritoneal and pulmonary tuberculosis. Standard treatment could not be administered. Therefore, trea...

(This article belongs to the Special Issue Gastrointestinal Health: Clinical Research and Therapeutic Innovations)
  • Article
  • Open Access
235 Views
22 Pages

24 September 2026

Staphylococcus epidermidis biofilms are inherently tolerant to antimicrobial treatment, contributing to the persistence and recurrence of biofilm-associated infections. In this study, we examined the phenotypic and proteomic responses of S. epidermid...

(This article belongs to the Section Bacterial Pathogens)
  • Article
  • Open Access
4 Citations
2,846 Views
17 Pages

Combined System for the Simultaneous Delivery of Levofloxacin and Rifampicin: Structural and Functional Properties and Antibacterial Activity

  • Irina M. Le-Deygen,
  • Polina V. Mamaeva,
  • Anna A. Skuredina,
  • Anastasia S. Safronova,
  • Natalia G. Belogurova and
  • Elena V. Kudryashova

The therapy of resistant forms of tuberculosis requires the simultaneous use of several drugs, in particular, a combination of rifampicin and levofloxacin. In this paper, we aimed to design a combined system for the simultaneous delivery of these dru...

(This article belongs to the Special Issue Antibacterial Materials: Recent Advances in Methodologies and Regulations)
  • Article
  • Open Access
6 Citations
3,966 Views
11 Pages

Molecular Characterization of Rifampicin-Resistant Staphylococcus aureus Isolates from Retail Foods in China

  • Jiahui Huang,
  • Feng Zhang,
  • Jumei Zhang,
  • Jingsha Dai,
  • Dongli Rong,
  • Miao Zhao,
  • Juan Wang,
  • Yu Ding,
  • Moutong Chen and
  • Qingping Wu
  • + 3 authors

4 December 2021

This study investigated the molecular characteristics of rifampin-resistant (RIF-R) Staphylococcus aureus isolates recovered from 4300 retail food samples covering most provincial capitals in China, from 2011 to 2016. Of the 1463 S. aureus enrolled,...

  • Article
  • Open Access
9 Citations
2,860 Views
16 Pages

NLC-Based Rifampicin Delivery System: Development and Characterization for Improved Drug Performance Against Staphylococcus aureus

  • Javiera Carrasco-Rojas,
  • Felipe I. Sandoval,
  • Christina M. A. P. Schuh,
  • Carlos F. Lagos,
  • Javier O. Morales,
  • Francisco Arriagada and
  • Andrea C. Ortiz

Background/Objectives: Rifampicin is a typical antibiotic used for the treatment of Staphylococcus aureus (S. aureus) infections; however, its clinical utility is limited by poor aqueous solubility, chemical instability, and increasing bacterial resi...

(This article belongs to the Special Issue Nanoparticle-Mediated Targeted Drug Delivery Systems)
  • Article
  • Open Access
18 Citations
4,561 Views
14 Pages

α-Synuclein oligomers are thought to play an important role in the pathogenesis of dementia with Lewy bodies (DLB). There is no effective cure for DLB at present. Previously, we demonstrated that in APP- and tau-transgenic mice, oral or intranasal ri...

(This article belongs to the Special Issue Alzheimer’s Disease and Other Dementias-Novel Therapeutic Approaches-2nd Edition)
  • Article
  • Open Access
5 Citations
4,120 Views
12 Pages

Inactivation of a New Potassium Channel Increases Rifampicin Resistance and Induces Collateral Sensitivity to Hydrophilic Antibiotics in Mycobacterium smegmatis

  • Thi Thuy Do,
  • Jerónimo Rodríguez-Beltran,
  • Esmeralda Cebrián-Sastre,
  • Alexandro Rodríguez-Rojas,
  • Alfredo Castañeda-García and
  • Jesús Blázquez

Rifampicin is a critical first-line antibiotic for treating mycobacterial infections such as tuberculosis, one of the most serious infectious diseases worldwide. Rifampicin resistance in mycobacteria is mainly caused by mutations in the rpoB gene; ho...

(This article belongs to the Section Mechanism and Evolution of Antibiotic Resistance)
  • Article
  • Open Access
5 Citations
3,201 Views
8 Pages

Comparative Performance of Line Probe Assay and GeneXpert in the Detection of Rifampicin Monoresistance in a TB-Endemic African Country

  • Betty R. Mchaki,
  • Fauster X. Mgaya,
  • Peter P. Kunambi,
  • Bernard Hang’ombe,
  • Mecky I. Matee and
  • Musso Munyeme

27 October 2022

Rapid, accurate and reliable assays are required for timely detection of drug-resistant tuberculosis and early initiation of second-line TB treatment as well as to minimize transmission of resistant strains. This study assessed diagnostic performance...

(This article belongs to the Section Antibiotic Therapy in Infectious Diseases)
  • Article
  • Open Access
14 Citations
5,660 Views
13 Pages

The cell-to-cell transmission of tau aggregates is considered a mechanism underlying the intracerebral spreading of tau pathology in Alzheimer’s disease (AD) and other tauopathies. Recent studies suggest that tau oligomers, rather than fibrils,...

(This article belongs to the Special Issue Alzheimer's Disease—115 Years after Its Discovery)
  • Article
  • Open Access
3 Citations
2,709 Views
13 Pages

Additive Effects of Cyclic Peptide [R4W4] When Added Alongside Azithromycin and Rifampicin against Mycobacterium avium Infection

  • Melissa Kelley,
  • Kayvan Sasaninia,
  • Arbi Abnousian,
  • Ali Badaoui,
  • James Owens,
  • Abrianna Beever,
  • Nala Kachour,
  • Rakesh Kumar Tiwari and
  • Vishwanath Venketaraman

18 August 2023

Mycobacterium avium (M. avium), a type of nontuberculous mycobacteria (NTM), poses a risk for pulmonary infections and disseminated infections in immunocompromised individuals. Conventional treatment consists of a 12-month regimen of the first-line a...

  • Case Report
  • Open Access
2 Citations
4,845 Views
6 Pages

According to current European Society of Cardiology guidelines, for staphylococcal prosthetic valve endocarditis, rifampicin should be one of the drugs used. However, there is a concomitant need for vitamin K antagonists in patients with mechanical p...

  • Article
  • Open Access
7 Citations
3,771 Views
20 Pages

Exploring Gut Microbial Dynamics and Symbiotic Interaction in Blattella germanica Using Rifampicin

  • Monica Cazzaniga,
  • Rebeca Domínguez-Santos,
  • Jesús Marín-Miret,
  • Rosario Gil,
  • Amparo Latorre and
  • Carlos García-Ferris

3 July 2023

Blattella germanica harbours two cohabiting symbiotic systems: an obligate endosymbiont, Blattabacterium, located inside bacteriocytes and vertically transmitted, which is key in nitrogen metabolism, and abundant and complex gut microbiota acquired h...

(This article belongs to the Special Issue Gut Microbiome in Health and Disease)
  • Article
  • Open Access
30 Citations
6,278 Views
12 Pages

In this study, we examined the in vitro effect of tobramycin-efflux pump inhibitor (TOB-EPI) conjugates in combinations with fluoroquinolones, rifampicin and fosfomycin on the growth of multi-drug resistant (MDR) and extremely-drug resistant (XDR) Ps...

(This article belongs to the Special Issue Advances in Antibacterial Drug Discovery and Therapy)
  • Article
  • Open Access
13 Citations
3,128 Views
22 Pages

Biodegradable and Bioactive Carriers Based on Poly(betulin disuccinate-co-sebacic Acid) for Rifampicin Delivery

  • Daria Niewolik,
  • Barbara Bednarczyk-Cwynar,
  • Piotr Ruszkowski,
  • Alicja Kazek-Kęsik,
  • Grzegorz Dzido and
  • Katarzyna Jaszcz

This paper describes the preparation and characterization of polymer-drug systems based on polymeric microspheres obtained from poly(betulin disuccinate-co-sebacic acid). The active compound that was coupled to the betulin-based carriers was rifampic...

(This article belongs to the Special Issue Biodegradable Polymers for Pharmaceutical Applications)
  • Article
  • Open Access
24 Citations
6,988 Views
20 Pages

Development and Evaluation of Physiologically Based Pharmacokinetic Drug–Disease Models for Predicting Rifampicin Exposure in Tuberculosis and Cirrhosis Populations

  • Muhammad F. Rasool,
  • Sundus Khalid,
  • Abdul Majeed,
  • Hamid Saeed,
  • Imran Imran,
  • Mohamed Mohany,
  • Salim S. Al-Rejaie and
  • Faleh Alqahtani

The physiologically based pharmacokinetic (PBPK) approach facilitates the construction of novel drug–disease models by allowing incorporation of relevant pathophysiological changes. The aim of the present work was to explore and identify the di...

(This article belongs to the Special Issue Pharmacokinetics in Optimizing Dosing)
  • Communication
  • Open Access
10 Citations
4,152 Views
13 Pages

Safety of Rifampicin at High Dose for Difficult-to-Treat Tuberculosis: Protocol for RIAlta Phase 2b/c Trial

  • Juan Espinosa-Pereiro,
  • Samiksha Ghimire,
  • Marieke G. G. Sturkenboom,
  • Jan-Willem C. Alffenaar,
  • Margarida Tavares,
  • Sarita Aguirre,
  • Arturo Battaglia,
  • Gladys Molinas,
  • Teresa Tórtola and
  • Cecile Magis-Escurra
  • + 2 authors

Previous clinical trials for drug-susceptible tuberculosis (DS-TB) have shown that first-line treatment with doses of rifampicin up to 40 mg/kg are safe and increase the early treatment response for young adults with pulmonary tuberculosis. This may...

(This article belongs to the Special Issue Dosing Strategies for Protecting the Vulnerable)
  • Article
  • Open Access
21 Citations
7,446 Views
13 Pages

Stability Study of Isoniazid and Rifampicin Oral Solutions Using Hydroxypropyl-Β-Cyclodextrin to Treat Tuberculosis in Paediatrics

  • Ana Santoveña-Estévez,
  • Javier Suárez-González,
  • Amor R. Cáceres-Pérez,
  • Zuleima Ruiz-Noda,
  • Sara Machado-Rodríguez,
  • Magdalena Echezarreta,
  • Mabel Soriano and
  • José B. Fariña

(1) Background: First-line antituberculosis treatment in paediatrics entails the administration of Isoniazid, Pyrazinamide, and Rifampicin. This study examines the possibility of developing a combined dose liquid formulation for oral use that would f...

(This article belongs to the Special Issue Paediatric Drug Delivery)
  • Article
  • Open Access
73 Citations
12,329 Views
9 Pages

Glucan Particle Encapsulated Rifampicin for Targeted Delivery to Macrophages

  • Ernesto Soto,
  • Yun Seong Kim,
  • Jinhee Lee,
  • Hardy Kornfeld and
  • Gary Ostroff

6 December 2010

Glucan particles (GPs) are 2–4 mm spherical, hollow, porous shells extracted from Baker’s yeast, Saccharomyces cerevisae. The surface of the GPs is composed primarily of 1,3-b-glucan and the particles are efficiently phagocytosed via receptor-mediate...

(This article belongs to the Special Issue Polyelectrolytes)

of 15